Kenvue earnings top estimates in J&J spinoff's first quarterly report since IPOJ&J still owns a 90% stake in Kenvue, meaning it can generally control the direction of the consumer health spinoff’s business for the time being.[Collection]

J&J still owns a 90% stake in Kenvue, meaning it can generally control the direction of the consumer health spinoff’s business for the time being.https://www.cnbc.com/2023/07/20/kenvue-kvue-q2-earnings-report-2023.html